CoChat

Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance?

Open access
Udy, Andrew A, Lipman, Jeffrey, Jarrett, Paul, Klein, Kerenaftali, Wallis, Steven C, Patel, Kashyap, Kirkpatrick, Carl MJ, Kruger, Peter S, Paterson, David L, Roberts, Michael S, Roberts, Jason A · 2015 · Critical Care
Cited by 138

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Introduction: The aim of this study was to explore the impact of augmented creatinine clearance and differing minimum inhibitory concentrations (MIC) on piperacillin pharmacokinetic/pharmacodynamic (PK/PD) target attainment (time above MIC (f T>MIC)) in critically ill patients with sepsis receiving intermittent dosing. Methods: To be eligible for enrolment, critically ill patients with sepsis had to be receiving piperacillin-tazobactam 4.5 g intravenously (IV) by intermittent infusion every 6 hours for presumed or confirmed nosocomial infection without significant renal impairment (defined by a plasma creatinine concentration greater than 171 μmol/L or the need for renal replacement therapy). Over a single dosing interval, blood samples were drawn to determine unbound plasma piperacillin concentrations. Renal function was assessed by measuring creatinine clearance (CL CR). A population PK model was constructed, and the probability of target attainment (PTA) for 50% and 100% f T>MIC was calculated for varying MIC and CL CR values. Results: In total, 48 patients provided data. Increasing CL CR values were associated with lower trough plasma piperacillin concentrations (P < 0.01), such that with an MIC of 16 mg/L, 100% f T>MIC would be achieved in only one-third (n = 16) of patients. Mean piperacillin clearance was approximately 1.5-fold higher than in healthy volunteers and correlated with CL CR (r = 0.58, P < 0.01). A reduced PTA for all MIC values, when targeting either 50% or 100% f T>MIC, was noted with increasing CL CR measures. Conclusions: Standard intermittent piperacillin-tazobactam dosing is unlikely to achieve optimal piperacillin exposures in a significant proportion of critically ill patients with sepsis, owing to elevated drug clearance. These data suggest that CL CR can be employed as a useful tool to determine whether piperacillin PK/PD target attainment is likely with a range of MIC values.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13054-015-0750-y

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 138

Metadata

Authors
Udy, A. A., Lipman, J., Jarrett, P., Klein, K., Wallis, S. C., Patel, K., Kirkpatrick, C. M., Kruger, P. S., Paterson, D. L., Roberts, M. S., & Roberts, J. A.
Venue
Critical Care
Published
2015-12
Volume
19
Issue
1
Pages
28-28
ISSN
1364-8535 (ISSN-L)
OpenAlex
W1998853564
Cited by
138
References
5
FWCI
11.84
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance? https://app.cochat.ai/papers/10.1186/s13054-015-0750-y
The paper
Udy, A. A., Lipman, J., Jarrett, P., Klein, K., Wallis, S. C., Patel, K., Kirkpatrick, C. M., Kruger, P. S., Paterson, D. L., Roberts, M. S., & Roberts, J. A. (2015). Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance? Critical Care. https://doi.org/10.1186/s13054-015-0750-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.